Filing Details

Accession Number:
0001209191-15-052366
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-11 17:24:04
Reporting Period:
2015-06-10
Filing Date:
2015-06-11
Accepted Time:
2015-06-11 17:24:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1393434 Ocular Therapeutix Inc OCUL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1354802 M Charles Warden C/O Ocular Therapeutix, Inc.
34 Crosby Drive, Suite 105
Bedford MA 01730
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-06-10 424,494 $22.00 2,520,499 No 4 S Indirect See Footnote
Common Stock Disposition 2015-06-10 2,506 $22.00 14,885 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. These securities are directly held by Versant Venture Capital III, L.P. Versant Ventures III, LLC is the general partner of Versant Venture Capital III, L.P. The Reporting Person is a mananging member of Versant Ventures III, LLC and disclaims beneficial ownership of the securities listed above except to the extent of his pecuniary interest, if any, therein.
  2. These securities are directly held by Versant Side Fund III, L.P. Versant Ventures III, LLC is the general partner of Versant Side Fund III, L.P. The Reporting Person is a mananging member of Versant Ventures III, LLC and disclaims beneficial ownership of the securities listed above except to the extent of his pecuniary interest, if any, therein.